^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
AVENIO ctDNA Targeted Kit

Company:
Roche
Type:
Laboratory Developed Test
Related tests:

Details

Evidence
News
Twitter
The AVENIO ctDNA Targeted Kit is a next-generation sequencing (NGS) liquid biopsy assay that contains 17 genes may be used for pan-cancer research applications, but is specially optimized for lung cancer and colorectal cancer (CRC). The AVENIO ctDNA Targeted Kit is an efficient tumor profiling solution. Accurate detection of all four mutation classes with high sensitivity and specificity: >99% sensitivity for SNVs, indels, CNVs, and fusions; >99% positive predictive value (PPV) for all classes of mutations.
Cancer:
Colorectal Cancer, Lung Cancer
Gene:
ALK (Anaplastic lymphoma kinase), APC (APC Regulator Of WNT Signaling Pathway), BRAF (B-raf proto-oncogene), BRCA1 (Breast cancer 1, early onset), BRCA2 (Breast cancer 2, early onset), DPYD (Dihydropyrimidine Dehydrogenase)
See More ...
Method:
Next-Generation Sequencing (NGS)